Resilience Care announced securing funding of €5 million led by Singular.

Resilience Care, a Paris, France-based startup building a software-based solution for cancer treatment providers and patients, announced that it completed a funding round of €5 million ($6M).

The money was raised from investors from France, led by Singular VC and including contributions from angels Nathalie Balla (La Redoute), Xavier Niel (Free), Jean-Charles Samuelian (Alan), Roxanne Varza (Station F), Charles Ferté (AstraZeneca), Philippe Dabi (Bioclinic) and Thomas Clozel (Owkin).

Resilience, founded in 2020 by Co-CEOs Céline Lazorthes and Jonathan Benhamou together with Nicolas Helleringer and Matthieu Pozza, is working for developing what they call a full-stack software solution for cancer treatment for both the medical team and patients. The goal is to develop a software tool that will use machine learning in order to intepret all sorts of information extracted from scientific literature and a history of other cancer cases, in order to provide a SAAS solution that can augment therapeutic decisions.